News

Chronic back pain may not be as it seems. Many patients suffer for years before being diagnosed with axial spondyloarthritis.

Retrospective study results indicate that golimumab may be a new and effective choice for maintaining remission and preventing recurrence of severe, recurrent anterior uveitis in patients with HLA-B27-positive ankylosing spondylitis.

A small British study indicates that the use of several immunosuppressive agents can restore the effectiveness of ustekinumab (Stelara) in patients with psoriasis and psoriatic arthritis.

“Physical exercise is an essential component of any treatment for fibromyalgia, and plenty of studies have demonstrated that low-impact aerobic exercise offers the most benefits," said Jamil Natour, MD, PhD.

Cushingoid appearance is a side effect of glucocorticoid use, but to date, there has been little knowledge about how glucocorticoids can change fat mass and redistribution.

A new study finds that slightly more than one-third of the patients were adherent to their index biologic and almost half discontinued within 12 months of initiation of therapy.

While it has been known for some time that psoriasis patients are at increased risk of developing cardiovascular disease and other comorbidities, new research has shown that these patients also have a higher risk of developing aortic aneurysms.

Many psoriasis patients wish they were better informed of the significant impact their skin condition would have on their physical and mental health, according to results from Psoriasis in America 2016, a Health Union national survey.

Identifying quality indicators will be important under MACRA. Some say quality indicators are true measurements that reflect the standard of care.

The blistering pace of mobile innovation has opened countless doors for clinical application. Built on Apple's ResearchKit platform, GSK's PARADE app seeks to study rheumatoid arthritis patients in their daily lives.

Patients afflicted with severe psoriasis may be at higher risk for chronic pancreatitis (CP).

Rheumatology nurses play an important role in identifying patients who may have hypermobility, a condition marked by painful joints capable of a long range of motion, says Dr. Rodney Grahame who spoke at RNS16.

Analysis of data from 2 large trials finds that cutoffs used to separate different “disease activity states” on the Disease Activity index for Psoriatic Arthritis (DAPSA) are valid. Different disease activity states are associated with different degrees of functional impairment and joint damage progression.

In this Q&A, Rheumatology Network speaks with Dr. Barbara Vilen who is making strides in both basic and translational research that may lead to new therapeutic targets for lupus.

In this Q&A, Rheumatology Network speaks with Dr. Stephen Katz about the NIAMS Action Plan for Lupus Research.

Observed improvements were not statistically significant above placebo, and there remains no approved medication for adolescent sufferers of fibromyalgia.

With the hope of wasting less time on medications doomed to fail, researchers are seeking biomarkers to predict a patient’s response to particular RA treatments.

In this article, we ask the experts to share their thoughts on the roots of doctor-patient communication challenges. Overwhelmed patients, busy doctors and technological communication rose to the top.

Popularly sold to improve joint health, a recent Spanish study found the benefits of CS+GS supplements on par with (and in some cases outperformed by) placebos.

Pain and sleep problems commonly go hand-in-hand. However, obstructive sleep apnea (OSA), daytime sleepiness, and poor sleep quality are all very different things.

Gout’s relationship with food intake can be tricky, so which is better: Eating foods lower on the glycemic index scale or lower in carbohydrates?

The gut microbiome has previously been considered a therapeutic target for the immune system, and new research suggests the microbiome’s composition can hold the key to managing psoriasis.

Saying the Guidelines fill a “significant clinical void,” the organization celebrated awareness of the rheumatic condition with a series of stringently approved recommendations for its treatment.

Biologics only slightly reduce fatigue in rheumatoid arthritis (RA) patients, a systematic review suggests.

In patients with CNS lupus, early evidence shows the presence of the development of dementia, says Dr. Yehuda Shoenfeld of Israel. "Lupus is a disease of young females, so it's not elderly females with dementia at this age."

In this story, we revisit the clinical trials that led to the approval of adalimumab for uveitis.

CPPD disease, once known as pseudogout, is underdiagnosed. A thorough analysis of synovial fluid can help improve outcomes, researchers say.

An unorthodox treatment for rheumatoid arthritis is gaining steam in the laboratory.

What happens when someone with psoriatic arthritis also has fibromyalgia? Researchers from Tel Aviv University in Israel were determined to find out.